SCHEMBL6600821

SCHEMBL6600821

CCSc1c(OC2CCCCO2)ccc2c1cnn2C1(I)CCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5419556 0.79 RXRA (0.39) —
SCHEMBL5409247 0.68 RXRA (0.38) —
SCHEMBL5425273 0.64 RXRA (0.40) —
SCHEMBL5419719 0.61 RXRA (0.38) —
SCHEMBL5413171 0.60 RXRA (0.40) —
SCHEMBL5418094 0.60 RXRA (0.42) —
SCHEMBL5407927 0.60 RXRA (0.38) —
SCHEMBL5417592 0.60 RXRA (0.40) —
SCHEMBL5413130 0.60 RXRA (0.38) —
SCHEMBL5412256 0.58 RXRA (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1403255-A1 Rho KINASE INHIBITORS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-03-31 — — EP disclosed
Send feedback